搜索结果1-10 的 27991 / ���������������������������op������r���:za33���

  1. Untitled

    Page 1.

  2. Untitled

    Page 1.

  3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  4. 麻醉与围术期医学科- 临床试验- 妙佑医疗国际

    The current operative standard is to infiltrate the eye socket with 0.5% bupivacaine during surgery leading to several hours of postoperative analgesia. In ...

  5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (R/R AML). The dose escalation (Part A) of the study will explore escalating intravenous doses of CC-96191 to estimate the MTD and/or RP2D of CC-96191 as ...

  6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (R/R AML). The dose escalation (Part A) of the study will explore escalating intravenous doses of CC-96191 to estimate the MTD and/or RP2D of CC-96191 as ...

  7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (R/R) multiple myeloma (MM). A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma. Rochester, Minn., Eau Claire, Wis. The ...

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (R/R) multiple myeloma (MM). A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma. Rochester, Minn., Eau Claire, Wis. The ...